TABLE 1.
Genes | Variants | Associated phenotypes | References |
GSK3B | rs6438552 | Brain structural changes in major depressive disorder (MDD) | Inkster et al., 2009 |
rs6438552 rs334558 |
Age of onset of bipolar disorder (BD) in female patients Response to lithium treatment |
Lin et al., 2013 | |
Haplotype containing rs334558 and rs3755557 | Response to lithium treatment | Iwahashi et al., 2014 | |
rs334558 | Response to lithium augmentation | Adli et al., 2007 | |
rs334558 | Gray matter volumes in the right frontal lobe of patients with BD | Benedetti et al., 2015 | |
rs334558 | Remission in patients with depressive disorders | Levchenko et al., 2018 | |
rs334558, rs13321783, rs2319398 | Response to antidepressant therapy | Tsai et al., 2008 | |
rs12630592 | Severity of mania (in both acute and stabilized periods) and depression in stabilized periods | Bureau et al., 2017 | |
Haplotype containing rs334555, rs119258668, and rs11927974 | Age of onset of MDD | Saus et al., 2010 | |
Interaction of rs6782799, rs6265 (BDNF), and negative life events | MDD | Yang et al., 2010 | |
BDNF | rs6265 | MDD | Tsai et al., 2003; Schroter et al., 2020 |
Interaction of rs6265 and stressful life events | MDD | Hosang et al., 2014 | |
rs6265 | Recurrent MDD | Xiao et al., 2011; Lee Y. et al., 2013 | |
rs6265 | Severity of depression | Losenkov et al., 2020 | |
rs6265 | Response to antidepressant therapy and remission in MDD | Choi et al., 2006; Alexopoulos et al., 2010; Chi et al., 2010; Zou et al., 2010; Taylor et al., 2011; Murphy et al., 2013; Wang et al., 2014; Colle et al., 2015; Xin et al., 2020 | |
rs712442 | Response to antidepressant therapy | Ochi et al., 2019 | |
NGF | Haplotype containing rs2254527, rs6678788, and rs12760036 | Remission rate in MDD | Yeh et al., 2015 |
Interaction with BDNF, among 590 other polygenes | Suicide attempt | Sokolowski et al., 2016 | |
NRG1 | rs4733272 (together with other chromosome 8-associated SNPs) | Schizophrenia, BD and MDD | Chen et al., 2017 |
rs4236710 and rs4512342; haplotype containing rs4512342 and rs6982890 rs2919375 Haplotype containing rs4531002 and rs11989919 |
Schizophrenia MDD MDD and BD |
Wen et al., 2016 | |
rs35753505 and rs7014762 | BD | Mei and Nave, 2014 | |
rs6994992, rs2439272, rs62510682, rs10503929, and rs3924999 | Prepulse inhibition (PPI, a measure of inhibitory sensorimotor gating) | Hong et al., 2008; Roussos et al., 2011 | |
rs6994992 | Activity of frontal and temporal lobes, premorbid IQ, and positive symptoms in schizophrenia | Hall et al., 2006; Papiol et al., 2011 | |
rs3924999 | Perceptual aberrations in schizotypal personality disorder | Lin et al., 2005 | |
HTR2C | rs6318 | Severity of depression | Brummett et al., 2014 |
rs6318 | Response to antidepressant therapy | Vyalova et al., 2017 | |
rs6318 | Suicide attempt | Karanovic et al., 2015 | |
rs6318 | Dysregulated stress responding and risk for depression | Avery and Vrshek-Schallhorn, 2016 | |
rs6318 | Stress-induced mesoaccumbal dopamine release | Mickey et al., 2012 | |
rs6318 and rs3813929 | Feeding behavior and antipsychotics-induced weight gain and movement disorders | Drago and Serretti, 2009 | |
rs1414334 | Metabolic syndrome in patients using antipsychotics | Mulder et al., 2009; Risselada et al., 2012 | |
PIP4K2A | rs10828317 | Tardive dyskinesia in schizophrenia patients | Fedorenko et al., 2014 |
rs10828317 | Schizophrenia | Schwab et al., 2006; Bakker et al., 2007; Fedorenko et al., 2013 | |
rs10828317 and rs10430590 | CGI-S total score at day 28 of antidepressant therapy | Vyalova et al., 2017 | |
rs11013052 | Schizophrenia | Saggers-Gray et al., 2008 | |
rs8341 | Schizophrenia | He et al., 2007 | |
Various intronic deletions and insertions 29 bp from the exon 9–intron 9 junction | BD | Stopkova et al., 2003 |